Skip to main content

Utilization of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitor Drugs: A Descriptive Analysis

    Basic Details
    Date Posted
    Medical Product
    obesity drugs
    sodium-glucose co-transporter-2 (SGLT-2) inhibitor

    This report presents incidence and counts of 11 generic names contained in the National Drug Code (NDC) directory. Results include total and incident counts of dispensing of the selected drugs (generic names) among enrolled members in the Sentinel Distributed Database (SDD) from 2008 - 2017. Counts and incidence are calculated with 90-day, 180-day, and 270-day washout periods. Results are stratified by year.

    The study period includes data from January 1, 2000 to August 31, 2018. We distributed this request to 17 Sentinel Data Partners on May 17, 2019.


    Additional Details
    FDA Center
    Time Period
    January 1, 2000 - August 31, 2018
    Analysis Type
    Summary Table
    Population / Cohort
    All individuals
    Data Sources
    Sentinel Distributed Database (SDD)